17 participants
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-04-15
- Start Date:
- 2018-05-16
- Completion:
- 2021-02-01
Conditions
- Cancer
Interventions
- DRUG
No Results Yet